During inflammation, lymphatic vessels sprout and proliferate within the infiltrated tissues [
23], to facilitate the homing of leukocytes, eliminate the antigens, and drain the interstitial fluid from the inflammatory site [
24]. However, there is a void in the literature regarding the contribution of lymphangiogenesis in periodontal wound healing and bone loss [
25]. The lymphangiogenesis-related genes
PROX1 [
26],
LYVE1 [
27], and
PDPN [
28] are mainly used to distinguish lymphatic vessels from blood vessels. Current findings demonstrated that these genes were expressed in diseased and healthy gingival biopsies indicating a lymphangiogenesis potential in both types of tissue. However, the significantly greater expression of
PROX1 found in diseased tissues implies the presence of residual inflammation that was also clinically evident. The lymphatic response is known to be long-lasting, even after the inflammatory challenge has been removed [
23], and if inflammation reoccurs, the remaining expanded vessel network contributes to the initiation of adaptive immune responses [
29]. Although an increased vessel network is associated with inflammation resolution, lymphangiogenesis has also been demonstrated to play a role in perpetuating chronic inflammatory disorders [
30]. Thus, the responses of lymphatic endothelial cells within the chronically inflamed gingivae may shed light into periodontal pathogenesis and this remains to be further studied.
The gene profiling in the inflamed and non-inflamed gingival tissues demonstrated that out of the 84 study key genes that are central to wound healing, 65 were expressed in both inflamed and healthy gingival tissues. However, gene expression between the pair-matched tissue specimens significantly differed for six genes;
TGF-α,
EGFR,
TGF-β1,
COL5A3,
MIF, and
ITGA3. The
TGF-α and
TGF-β1 are important growth factors in periodontal healing but they have distinct biological roles. Transforming growth factor-alpha acts as a ligand for the epidermal growth factor receptor (
EGFR), triggering cell proliferation, differentiation, and development [
31]. Transforming growth factor-beta-1 promotes the production of GT by enhancing the expression of extracellular matrix (ECM)-related genes such as fibronectin, fibronectin receptor, collagen, and protease inhibitors [
32]. It is also implicated in the recruitment of inflammatory cells and enhancement of tissue debridement by macrophages [
32,
33]. In line with current findings,
TGF-β1 mRNA expression has been found higher in gingival tissue obtained from patients with periodontitis when compared to tissue harvested from subjects free of periodontitis [
34]. In the current study, macrophage migration inhibitory factor (
MIF) was significantly upregulated in GT samples. Macrophage inhibitory factor is a pro-inflammatory mediator [
35] and has been shown to contribute to both the inflammatory and migration/proliferation phases of wound healing [
36]. In the inflammatory phase, chronic expression of
MIF would serve to attenuate wound healing progression due to its potent inflammatory potential. Therapeutic targeting of
MIF might be promising in diseases with impaired/unbalanced wound healing [
36]. However, due to its pro-proliferative activity,
MIF expression may contribute to improving wound healing by exerting its effects on fibroblasts [
36], and this is central to periodontal regeneration. The current study indicated that
COL5A3 gene was significantly upregulated in GT samples. Collagen-V, a protein produced by the
COL5A gene, is the connector between the basement membrane and stroma and promotes cell attachment and migration [
37]. It has been shown to regulate the initiation of collagen fibril assembly, making it an essential regulator of fibril formation and matrix organization [
38]. A recent study has demonstrated that matrix containing
COL5A3 may be required for the initiation of wound healing [
39]. In addition,
ITGA3 was significantly upregulated in GT samples. Integrins are heterodimeric transmembrane proteins that play significant roles in cell proliferation, differentiation, cell-cell attachment, adhesion, and signal transduction between the cell and the ECM during developmental and pathological processes [
40]. They can also bind to other ECM proteins such as vitronectin, fibronectin, laminin, and collagen because of their adhesive nature [
41]. In conclusion, the upregulated genes in the diseased tissues were involved in the proliferation phases of wound healing by collagen deposition, matrix remodeling, and integrin signaling indicating that despite the remaining inflammatory stimulus, the infiltrated tissues are in a process of restoration, possibly for prolonged time.
Interestingly, a clinical study demonstrated that non-resective surgical approaches that retained the soft-tissue lining of the pocket led to greater residual lesions with greater densities of immunocompetent cells in the regenerated gingival tissues at 6 months [
9], implying an inferior healing outcome. However, a relatively short time frame for re-evaluation should be considered in that study design [
47]. The current study sheds light into the wound healing process of gingival tissues with remaining inflammation and follows up previous studies on this topic which investigated the outcomes of preserving the pocket gingival lining [
15,
17]. This in vitro study was conducted on tissue biopsies retrieved from six non-smoking donors, and despite a relatively small sample size of biopsies (three pairs of biopsies for each arm of the experiment), there was homogeneity in the donors in terms of a similar periodontal clinical status. Because of the small quantities of specimens, three donors were used for the gene profiling analysis and the remaining three for the cell culture assays. However, despite the different specimens used in the two experimental arms of the study, there was a consistent trend across all donors. It should be noted that the samples of health versus disease were pair-matched, to exclude any biological variability across donors. Further research is suggested to determine the role that the upregulated genes related to wound healing might play in a successful treatment outcome and whether the different components of the ECM might play a role in inflammation control and maturation of the GT into connective tissue.